Literature DB >> 22187102

Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice.

Jiangning Liu1, Wei Dong, Xiongzhi Quan, Chunmei Ma, Chuan Qin, Lianfeng Zhang.   

Abstract

Human PSGL-1 is a receptor for EV71 that facilitates EV71 entry and replication in mouse cells. We have evaluated the role of human PSGL-1 in EV71 infection in vivo using a transgenic mouse line. Expression of human PSGL-1 failed to enhance infectivity of clinical EV71 strains in mice; however, it promoted replication and symptom severity at an earlier stage in mice upon infection with a mouse-adapted EV71 strain. We therefore conclude that human PSGL-1 alone is not sufficient to modulate infection with the clinical EV71 strains of genotype C4 in mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187102     DOI: 10.1007/s00705-011-1198-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.

Authors:  Ken Fujii; Noriyo Nagata; Yuko Sato; Kien Chai Ong; Kum Thong Wong; Seiya Yamayoshi; Midori Shimanuki; Hiroshi Shitara; Choji Taya; Satoshi Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

2.  The Pathogenesis and Prevention of Encephalitis due to Human Enterovirus 71.

Authors:  Emily Jane Bek; Peter Charles McMinn
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 3.  Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection.

Authors:  Jingjun Xing; Ke Wang; Geng Wang; Na Li; Yanru Zhang
Journal:  Arch Virol       Date:  2022-09-29       Impact factor: 2.685

Review 4.  Progress on the research and development of human enterovirus 71 (EV71) vaccines.

Authors:  Zhenglun Liang; Qunying Mao; Fan Gao; Junzhi Wang
Journal:  Front Med       Date:  2012-12-17       Impact factor: 4.592

5.  Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71.

Authors:  Seiya Yamayoshi; Seii Ohka; Ken Fujii; Satoshi Koike
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

6.  Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases.

Authors:  Seiya Yamayoshi; Ken Fujii; Satoshi Koike
Journal:  Front Microbiol       Date:  2012-02-06       Impact factor: 5.640

7.  The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model.

Authors:  Chikako Kataoka; Tadaki Suzuki; Osamu Kotani; Naoko Iwata-Yoshikawa; Noriyo Nagata; Yasushi Ami; Takaji Wakita; Yorihiro Nishimura; Hiroyuki Shimizu
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

8.  Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.

Authors:  Yi-Wen Lin; Shu-Ling Yu; Hsiao-Yun Shao; Hsiang-Yin Lin; Chia-Chyi Liu; Kuang-Nan Hsiao; Ebenezer Chitra; Yueh-Liang Tsou; Hsuen-Wen Chang; Charles Sia; Pele Chong; Yen-Hung Chow
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

9.  Enterovirus 71 infection causes severe pulmonary lesions in gerbils, meriones unguiculatus, which can be prevented by passive immunization with specific antisera.

Authors:  Fang Xu; Ping-Ping Yao; Yong Xia; Lei Qian; Zhang-Nv Yang; Rong-Hui Xie; Yi-Sheng Sun; Hang-Jing Lu; Zi-Ping Miao; Chan Li; Xiao Li; Wei-Feng Liang; Xiao-Xiao Huang; Shi-Chang Xia; Zhi-Ping Chen; Jian-Min Jiang; Yan-Jun Zhang; Ling-Ling Mei; She-Lan Liu; Hua Gu; Zhi-Yao Xu; Xiao-Fei Fu; Zhi-Yong Zhu; Han-Ping Zhu
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

10.  Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy.

Authors:  Yueh-Liang Tsou; Yi-Wen Lin; Hsuen-Wen Chang; Hsiang-Yin Lin; Hsiao-Yun Shao; Shu-Ling Yu; Chia-Chyi Liu; Ebenezer Chitra; Charles Sia; Yen-Hung Chow
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.